Tag: Australian Pharma

Updated Obligations for Drug Shortage in Australia

The Australian medicines regulator has updated its guidance on reporting obligations for pharmaceutical companies, mandating confidential reporting of all shortages. The document, published by the ...

PCI Pharma to Produce AusCann’s First Treatment of Chronic Pain

Medical cannabis company AusCann has chosen PCI Pharma to manufacture and release its first product designed to help treat chronic pain. PCI Pharma will produce and release AusCann’s solid hard she...

First Australian CBD-Based Epilepsy Drug

After receiving formal authorisation to sell its “CannEpil” epilepsy drug treatment in Australia in October, ASX listed biotech, MGC Pharmaceuticals, has reached another milestone, with the arrival of...